RPT-EXCLUSIVE-As Olympics loom, Japanese approval of Moderna s COVID-19 vaccine unlikely till May Reuters 1/7/2021 Japan has secured more than enough vaccine orders But Japanese rules mean vaccine approvals lag others Tokyo Olympics scheduled to start in late July Takeda Pharmaceutical handling Japan s Moderna rollout
By Rocky Swift
TOKYO, Jan 7 (Reuters) - Moderna Inc s COVID-19 vaccine is unlikely to win approval in Japan until May due to requirements for local clinical trials, the distributor said, casting doubt over a nationwide vaccination rollout before the summer Tokyo Olympics.
With an eye on the Olympics due to start in late July, Japan has secured rights to at least 540 million doses of COVID-19 vaccines from several Western developers, the biggest quantity in Asia and more than enough for its 126 million population.
Dick Pound, the longest serving member of the International Olympic Committee (IOC), remains uncertain whether the Tokyo 2020 Games will go ahead. It comes after organisers said they will be ready to host the rescheduled Games - despite the city declaring a state of emergency over Covid-19. Pound said:…
TOKYO (Jan 7): Moderna Inc s Covid-19 vaccine is unlikely to win approval in Japan until May due to requirements for local clinical trials, the distributor said, casting doubt over a nationwide vaccination roll-out before the summer Tokyo Olympics.
With an eye on the Olympics due to start in late July, Japan has secured rights to at least 540 million doses of Covid-19 vaccines from several Western developers, the biggest quantity in Asia and more than enough for its 126 million population.
But Tokyo faces a major regulatory bottleneck due to requirements for local clinical trials before requesting approval. Several other countries have fast-tracked the review process to expedite mass inoculation.
Moderna Inc's COVID-19 vaccine is unlikely to win approval in Japan until May due to requirements for local clinical trials, the distributor said, casting doubt over a nationwide vaccination rollout before the summer Tokyo Olympics.
By Syndicated Content
By Rocky Swift
TOKYO (Reuters) - Moderna Inc s COVID-19 vaccine is unlikely to win approval in Japan until May due to requirements for local clinical trials, the distributor said, casting doubt over a nationwide vaccination rollout before the summer Tokyo Olympics.
With an eye on the Olympics due to start in late July, Japan has secured rights to at least 540 million doses of COVID-19 vaccines from several Western developers, the biggest quantity in Asia and more than enough for its 126 million population.
But Tokyo faces a major regulatory bottleneck due to requirements for local clinical trials before requesting approval. Several other countries have fast-tracked the review process to expedite mass inoculations.